Longevity Health Holdings, Inc. (XAGE) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Longevity Health Holdings, Inc.'s filing signal turned positive.

Longevity Health Holdings, Inc. is a bio-aesthetics company focused on longevity and healthy aging, developing cosmetic skincare and haircare products. Its primary offerings include the Elevai ExosomesTM and Carmell SecretomeTM product lines, which are formulated to support skin and hair health and are marketed to both professional care providers and retail consumers. The company also has a pipeline of regenerative bone and tissue healing products, though further research and development on these has been paused. Longevity Health Holdings sells its cosmetic products in the United States through business-to-business, direct-to-consumer, and distributor channels, and internationally through distributors. The company's strategy has recently refocused on the Elevai product line following its acquisition in January 2025.

Revenue is primarily driven by the sales of its cosmetic skincare and haircare products, specifically the Elevai ExosomesTM and Carmell SecretomeTM lines. The acquisition of the Elevai Skincare business in January 2025 significantly contributed to revenue in the most recent fiscal year.